Tesseract Medical Research

Recent Financing

Seed

Recent Raise

$20M

Tesseract Medicines develops covalent-induced-conjugate therapeutics that deliver cytotoxic payloads to cancer-relevant intracellular proteins, focusing on research and development of selective intracellular targeting to improve therapeutic index.

Founded 2016

California, United States

1-10

Private

tessmed.com

Highlights

Focus Areas

Alternative Medicine

Biotechnology

Fitness

Health Care

Wellness

Recent Investors

革

Financials

$20M

Total Raised

1

Funding round

3

Investors

Team

Upgrade to view the team

See the team members at Tesseract Medical Research.